The retrotransposon LINE-1 (L1) is a transposable element that has extensively colonized the mammalian germline. L1 retrotransposition can also occur in somatic cells, causing genomic mosaicism, as well as in cancer. However, the extent of L1-driven mosaicism arising during ontogenesis is unclear. Here we discuss recent experimental data which, at a minimum, fully substantiate L1 mosaicism in early embryonic development and neural cells, including post-mitotic neurons. We also consider the possible biological impact of somatic L1 insertions in neurons, the existence of donor L1s that are highly active ('hot') in specific spatiotemporal niches, and the evolutionary selection of donor L1s driving neuronal mosaicism.
A mosaic of genomes
Barbara McClintock discovered Ac/Ds transposition as the genetic basis for maize kernel variegation nearly 70 years ago [1, 2] . In this remarkable work, McClintock simultaneously identified mobile DNA and its transposition in somatic cells, hence explaining the observed mosaic kernel phenotype. Various forms of somatic genome mosaicism have since been described [3] in normal and disease contexts, in developing and adult tissues, involving DNA changes ranging from a single nucleotide to entire chromosomes, and, in some cases, being central to critical biological processes [4] . The mobile DNA field founded by McClintock has gone on to identify numerous transposable element (TE) families, which are arguably the preeminent feature of most eukaryotic genomes sequenced to date [5] and are a major source of genetic diversity and regulatory innovation [6, 7] . However, despite an ongoing emphasis on mammalian genomics, and the instructive effects of somatic transposition on plant biology revealed by McClintock and others, our understanding of TE mobilization in mammalian somatic cells remains in its infancy. In this Review, we focus on recent reports of Long INterspersed Element 1 (LINE-1, or L1) retrotransposition during murine and human embryogenesis and neurogenesis, discuss the potential biological significance of somatic L1 insertions, and consider how L1 mosaicism may be subject to evolutionary selection.
L1 retrotransposons
Retrotransposition is a molecular "copy-and-paste" process where an RNA template is reverse transcribed and integrated into the host genome, hence duplicating the donor DNA sequence from which the RNA was transcribed [8] . In humans, more than 500,000 L1 copies occupy ~17% of the genome [9] . An intact, full-length L1 is 6kb in length and initiates transcription 3 from a canonical 5' sense promoter (Figure 1a) . The L1 mRNA encodes two proteins (ORF1p and ORF2p) that catalyze L1 retrotransposition in cis [10] . The reverse transcriptase and endonuclease activities of ORF2p are indispensable to efficient retrotransposition [11] [12] [13] . L1 also encodes an antisense peptide, ORF0, which may assist L1 mobility [14] . Most new L1 copies are rendered immobile by 5ˈ truncation or internal mutation, leaving only 80-100 potentially mobile L1s per individual human genome [15, 16] . Of these, fewer than 10 are expected to mobilize efficiently if tested in vitro and are therefore described as "hot" L1s [15, [17] [18] [19] . The vast majority of hot L1s belong to one subfamily (L1-Ta, for Transcribed-Active) [15, 17] . Although L1 is the only remaining mobile, autonomous human TE, the non-autonomous retrotransposon families Alu (a Short INterspersed Element, or SINE) and SVA (a composite element incorporating SINE-R, a variable number of GC-rich tandem repeats, Alu, and a 5ˈ hexamer) can be retrotransposed in trans by the L1 protein machinery, as can be other polyadenylated mRNAs, generating processed pseudogenes [20] [21] [22] [23] [24] . In mice, ~3000 L1 copies representing three subfamilies (TF, GF, A) remain retrotransposition-competent (Figure 1b (Figure 1a) and various other functional consequences [5, 6] . L1 insertions are, likely as a result of evolutionary selection, not randomly distributed on the genome and are depleted from exons and introns [52] . This mutagenic potential also means the L1 5ˈ promoter, if present in a new insertion, is heavily repressed by the host genome in most spatiotemporal contexts [48, [53] [54] [55] [56] (Figure 1d ). Even in situations where full-length L1 transcripts are detected, these are usually generated by a limited number of L1 copies [38, 50] . As a result, the L1 5ˈ promoter is a major battleground in what has often been described as an "arms race" pitting L1's interest to replicate against the host genome's interest to mitigate deleterious L1 mutations [57, 58] . Beyond transcriptional repression, the host genome has developed multiple strategies to limit ongoing retrotransposition [for reviews, see [59] [60] [61] [62] ].
Methods to detect L1 retrotransposition
Two core strategies are available to resolve the spatial and temporal extent of L1 retrotransposition: L1 reporter assays and high-throughput sequencing. In 1996, an L1 reporter assay [13] was adapted from an existing but ingenious design [8, 63] , and tagged human donor L1s with an intron-containing neomycin antibiotic resistance cassette [64] that was made functional by retrotransposition. In this assay, neomycin resistant foci function as a readout of L1 retrotransposition efficiency (Figure 2a, left) . Remarkably, frequent L1 retrotransposition events 5 carrying TPRT hallmarks were observed in human and mouse cells (Box 1) [13] . As an alternative approach, an enhanced green fluorescent protein (EGFP) based cassette was then developed, yielding an L1-EGFP construct where EGFP was made functional by retrotransposition (Figure 2a, right) [65] . This approach facilitated the use of fluorescencebased microscopy and flow cytometry to measure L1 retrotransposition efficiency, including for transgenic animals in vivo [66] . In all, these reporter L1s, and their derivatives (e.g. [67] ), have underpinned numerous studies elucidating retrotransposon biology over the past two decades, and remain commonly used and effective tools [for a review, see [68] ].
Alongside engineered L1 systems, high-throughput sequencing has massively increased our ability to characterize DNA variation in human populations [52] and cancer genomes [69] .
L1 insertions are, in this regard, just one type of DNA structural variant and can be studied en masse, either as part of a whole-genome sequencing (WGS) approach, or via targeted sequencing of L1-genome junctions (Figure 2b) . Either strategy requires careful computational analysis and experimental validation to confirm true L1 insertions [39, 61, 70] and typically leverage L1 polymorphism catalogs [71] [72] [73] to discriminate known and unknown L1 insertions. The bioinformatic identification of new L1 insertions from WGS data [52, [74] [75] [76] is advantageous in that it can reveal the 5' and 3' L1-genome junctions of an insertion, allowing substantial characterization of TPRT hallmarks a priori. As a result, WGS analyses tend to report fewer false positives and flexibly encompass more variations of TPRT (e.g. 3' transductions [35] [36] [37] and 5' inversions [42, 77] ) than can be discerned using targeted methods [30, 69, 78, 79] analyzing only one (usually the 3') L1-genome junction. Some targeted methods do however attempt to analyze both L1-genome junctions simultaneously [50, 80, 81] and, importantly, WGS remains far more expensive than targeted approaches. Both general strategies can be applied to "bulk" DNA 6 extracted from tissue or pooled cells, and to DNA amplified from individual cells [82, 83] . Highthroughput sequencing has greatly expanded our overall capacity to study endogenous L1s in vivo, as opposed to the considerable caveats of introducing a transgenic L1 into a new epigenetic landscape [53, 56, 66, 84, 85] . If, however, congruent experimental data are obtained from an L1
reporter and high-throughput sequencing applied to a common biological system, such as cultured stem cells [86, 87] , the conclusions are likely to be robust.
Heritable and somatic L1 retrotransposition during early development
How has L1 colonized nearly one-fifth of the human and mouse genomes? Heritable L1 insertions must, by definition, occur in a germ cell, or an embryonic cell contributing to the germ line. A landmark 1988 study reported L1 mutagenesis of the factor VIII gene of two hemophilia patients [42] . These results established that heritable de novo L1 insertions were still occurring in humans and that these mutations could cause disease. Nonetheless, the developmental origin of de novo L1 retrotransposition remained unclear [42] . Subsequent murine studies reported fulllength L1 mRNA and L1 ORF1p expression in blastocysts, male and female germ cells and, interestingly, placental syncytiotrophoblast cells [88] [89] [90] [91] . Differential L1 expression was observed during germ cell specification; for example, L1 ORF1p was detected in primordial spermatogonia, as well as the leptotene and zygotene stages of spermatogenesis, but not in mature spermatids [88, 91] . Together with later transgenic L1 mouse experiments [66, 85, [92] [93] [94] , recovery of endogenous L1 insertions from human germ cells [95] and studies of human Xlinked disease-causing L1 mutations [42, 96, 97] , these reports strongly suggested endogenous L1 mobilization could occur in germ cells and the early embryo.
Of highest relevance here is a study [97] that reported an L1 mutation associated with 7 choroideremia, a rare recessive X-linked condition, in an affected male proband. Notably, his mother was a somatic and germline mosaic for the L1 insertion. This example irrefutably demonstrated that endogenous L1 retrotransposition could occur early in human embryogenesis.
In addition, the de novo L1 insertion carried a 3ˈ transduction, allowing the authors to trace a full-length donor L1 and prove it mobilized efficiently in vitro using the L1 reporter assay [65, 97] In a recent analysis, targeted sequencing was performed on multiple cultured hESC and hiPSC lines, followed by PCR validation of candidate de novo insertions in multiple laboratories [87] . hiPSCs were reprogrammed from multiple parental cell types using a variety of approaches, again in several different laboratories. Eleven de novo L1, Alu and SVA insertions were PCR validated. These data confirmed that L1 was activated by reprogramming [100, 103] , a process known to involve wholesale epigenomic changes [104] . Interestingly, de novo L1 insertions identified in hiPSCs appeared unusually likely to be full-length, as found previously for L1-EGFP insertions in hiPSCs [100] but not in hESCs [86] . The characteristics of L1 activity may therefore be different in hiPSCs and hESCs, although an as yet unrealized catalog of endogenous L1 insertions in cultured hESCs would be required to test this possibility.
In comparing the rate of endogenous L1 mobilization in hiPSCs versus hESCs, we strongly urge consideration of how heterogeneous each cell population is. Methodological factors, such as 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 belonging to the TF subfamily, indicating a rate of at least 1 new L1 insertion per 8 births. Most heritable L1 insertions arose in the early embryo prior to germ cell specification, or in early primordial germ cells (PGCs). For L1 insertions traced to the early embryo and early PGCs, transmission to multiple offspring was routinely observed, suggesting that more than one allele of a given event may be produced in one generation due to DNA replication errors and poly(A) tail shortening post-integration [113] . TE diversity within inbred strains is therefore common and adds to inter-strain variation [26, 29] .
Importantly, this study also identified major depletion of the 3ˈ L1-genome junction for the active mouse L1 families in Illumina sequencing data [31], which was attributed to obstruction by an extensive G-quadruplex region [114, 115] . To our knowledge, this issue was not identified by previous genomic analyses of mouse L1 insertions using WGS [108, 116] and is potentially problematic for TE discovery and sensitivity calculations. For this reason, we consider the abovementioned figure of 1/8 to be conservative [31] . As well, data obtained from transgenic animals suggest that most engineered L1 retrotransposition occurs in the soma and are not inherited [56, 92, 93, 117] . Hence, heritable L1 insertions are likely far outnumbered by endogenous L1 insertions occurring in the embryo and later during ontogenesis and lineage specification.
Do mature neurons support L1 retrotransposition?
Over the last decade, the L1-EGFP reporter system, alongside other approaches, has been used to elucidate engineered L1 mobilization in neural progenitors arising during fetal and adult neurogenesis (Box 2), suggesting the brain may be a L1 mosaicism hotspot [53, 56, 84] . However, it remains unclear whether mature neurons, or other cell lineages, also accommodate L1 activity. 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Recently, a human L1-EGFP reporter was introduced into hESC derived neuronal precursor cells (NPCs) and, as seen previously [53, 56] , observed efficient retrotransposition was observed [99] .
The authors then exploited a hybrid L1 adenoviral vector [118] it was determined that the rate of L1-EGFP insertions in mature neurons was at least as high as in NPCs. These conclusions relied heavily on PCR and qPCR detection of the spliced EGFP cassette, and normalization to a plasmid or adenovirus [53] . If taken together, this study and previous studies focused on L1 in NPCs [53, 56, 99] , lead us to conclude that engineered L1 activity, in the cell types and physiological conditions tested thus far, is largely restricted to the neuronal lineage, including post-mitotic neurons.
Extent of endogenous L1 mobilization in the brain
Despite ongoing debate regarding the various types of mosaic DNA variation found in the brain [70, 81, [119] [120] [121] , an unequivocal consensus view, based on genomic analysis of bulk brain tissue [53, 80] nucleus revealed a single somatic L1 insertion, which carried a 5' transduction and could be PCR amplified and capillary sequenced in its entirety (an "empty/filled" assay, which we consider to be the highest validation standard). Another 4 events were detected by L1-IP but could be PCR amplified only at their 3' L1-genome junction. Subsequent WGS [83] applied to 16 of the MDAamplified cortical neurons analyzed by L1-IP, including the neuron where the archetypal neuronal L1 insertion [82] was found, re-identified that event as well as another somatic L1 insertion flanked by a 614nt 3' transduction that was, for this reason, initially overlooked by L1-IP [82] . Two additional single-cell studies of hippocampal and cortical neurons, via MDA followed by somatic L1-associated variant sequencing (SLAV-seq) [41] , and through multiple annealing and looping-based amplification cycles (MALBAC) followed by RC-seq [81] , also identified and PCR validated multiple somatic L1 variants. Hence, single-cell genomic analyses have consistently found strong evidence for endogenous L1 mobilization in the neuronal lineage (Table 1).   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 As a discipline still in its infancy, sequences fare during whole genome amplification. Moreover, it is interesting that engineered L1 insertions have been shown to accumulate mainly in post-mitotic neurons [99] , whereas the two somatic L1 insertions referred to above were each detected in multiple neurons [83] . These considerations lead us to ask whether the false negative rate has been consistently underestimated when assessing the degree of L1 mosaicism in the brain with single-cell genomics, whilst acknowledging that accurate false positive rate calculations are essential [81, 121] . Finally, it must be noted that single-cell genomic analyses of L1 mobilization have been performed on very few human brain samples thus far, and on broad neuronal types, leaving open the possibility that some individuals, brain regions and neuronal subtypes may support more endogenous L1 activity than others, and thus contribute to disparate somatic L1 retrotransposition frequency estimates.
To our knowledge, no single-cell analysis of endogenous L1 mobilization in the mouse brain has been reported to date. However, in an elegant study, somatic cell nuclear transfer (SCNT) was used to reprogram mESCs with neuronal nuclei obtained from the mouse olfactory bulb, followed by clonal expansion and bulk WGS to identify de novo TE insertions and other somatic variants [116] . This approach provided an excellent and robust alternative to wholegenome amplification and eliminated errors associated with the latter technique, although also 
When does L1 jump in brain development?
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Box 2. Engineered L1 mobilization in neural progenitor cells.
A 2005 study [56] discovered in vivo L1-EGFP mobilization in transgenic mouse neurons, and in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 cultured rat neural stem cells (NSCs) and neuronal precursor cells (NPCs), providing foundational evidence of an L1 mosaic mammalian brain. Amongst various key findings, the authors elucidated Sox2, a transcription factor required to maintain NSC identity [146] , as a repressor of the L1 5'UTR that is downregulated to complete neuronal maturation, hence providing a scenario for L1 mobilization [56, 147] . A significant caveat of this work was that it depended on a human L1 tagged with EGFP and integrated into the foreign epigenetic landscape of another species. As a follow on, a subsequent study [53] showed that the L1-EGFP reporter mobilized in human NPCs derived from fetal brain and hESCs in vitro, and that the CpG island at the core of the L1-Ta promoter [148] was partially demethylated in fetal brain when compared to non-neural tissues, further explaining L1 activation during neurogenesis. Through an L1
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• L1 retrotransposons can mobilize during embryogenesis, and in the neuronal lineage, causing somatic genome mosaicism.
• Genomic analysis of endogenous L1 mobilization in mouse pedigrees, and transgenic L1 rodents, has revealed the early embryo, prior to germ cell specification, as the primary niche for the accumulation of new, heritable L1 insertions.
• Neuronal progenitor cells and post-mitotic neurons accommodate engineered L1
retrotransposition, but other cell lineages support limited or no L1 activity, in the physiological conditions tested to date.
• L1 retrotransposition clearly occurs in the brain, based on data obtained from engineered L1
reporter systems and single-cell genomic analysis, but the relevant techniques and estimated L1 mobilization rates vary considerably.
• Donor L1s can be differentially active in germline and somatic cells, potentially influencing evolutionary selection of donor L1s that are highly active in the brain. • What is the frequency of endogenous L1 mobilization in the brain? It is accepted that L1
can jump in the brain, however the available rate estimates, and interpretations of the same data, vary widely. A focus on false positives should be complemented by a closer examination of false negatives, and standardization of techniques. L1 insertions are likely to occur in post-mitotic neurons, meaning even a low rate of neuronal L1 mobilization could generate a constellation of L1 variation amongst the ~10 11 neurons found in the human brain.
Is this mosaicism, however, variable among different neuronal subtypes?
• What are the immediate and broader functional consequences of somatic L1 insertions in the brain? Transcriptomic and genomic analysis of the same individual neuron could, at least, answer the first question. The impact of L1 mosaicism on neurobiology is a much more challenging and large-scale issue, with little clear evidence produced to date of somatic L1
insertions impacting neurological function, psychiatric disorders or neurodegenerative diseases.
• If, however, L1 mosaicism impacts neurobiology, it is plausible that donor L1s highly 
